- State University of New York, Brooklyn
Internship / Residency
- Presbyterian Hospital, University of Pennsylvania Medical Center, Philadelphia
- MS, Bioengineering - Polytechnic Institute of Brooklyn
- Hematology - Kings Country Hospital/Downstate Medical Center, Brooklyn
- Postdoctoral Fellow - The Rockefeller University, New York
Dr. Joel Granick is a medical oncologist at Cancer Treatment Centers of America® (CTCA), Phoenix. In discussing his role, Dr. Granick shows he is not afraid to get close to his patients: “At CTCA®, I get to know the whole patient, not just their cancer," he says.
Dr. Granick earned bachelor’s and master’s degrees from Polytechnic Institute of Brooklyn. He subsequently earned a medical degree from State University of New York in Brooklyn.
Following medical school, Dr. Granick completed an internship and residency at Penn Presbyterian Medical Center (part of the University of Pennsylvania Health System) in Philadelphia. He also completed a hematology fellowship at Kings County Hospital, SUNY Downstate Medical Center in New York.
In addition, Dr. Granick completed postdoctoral fellowship at The Rockefeller University in New York, where he later served as Assistant Professor and Chief Resident Physician. He has also been published in numerous medical journals and is the founding member of the American Academy of Hospice and Palliative Care.
Dr. Granick has been with CTCA since 1992. Prior to joining the care team at CTCA Phoenix, Dr. Granick served as the Director of Oncology Services and Palliative Care at CTCA in Suburban Chicago.
“I work with patients who have been mistreated elsewhere because their pain is not under control," says Dr. Granick. "I find great satisfaction in relieving pain, suffering and discomfort. This provides such a significant improvement in a patient's quality of life in such a great way.”
Patient ratings and comments
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.